analytical methods of determination , investigations of stability and the behaviour of the substance in artificial gastric and intestinal fluids are the bases for the formulation of an oral preparation of 14-hydroxy-3beta- [ 4-o-methyl-alpha-l-rhamnopyranosyl ) oxy ] -14beta-bufa-4,20,22-tr ienolide ( meproscillarin , clift ) .
C0439861
substance
C0005889
fluids